5 min read

Wildlife Trade, Cyber Sovereignty, and the Next Pandemic: Six Years After COVID-19

Wildlife Trade, Cyber Sovereignty, and the Next Pandemic: Six Years After COVID-19

How governments' internet policies continue to enable zoonotic disease risk

Six years have passed since the COVID-19 pandemic reshaped the world, yet the underlying infrastructure that made such an outbreak possible remains largely intact. While the wet markets of Wuhan are no longer making international headlines, the intersection of three forces—Traditional Chinese Medicine demand, wildlife farming incentives, and internet governance built around "cyber sovereignty"—continues to create conditions for the next spillover event. This time, policymakers have fewer excuses for inaction.

The legitimization problem: WHO's 2018 decision still ripples today

In 2018, the World Health Organization formally incorporated Traditional Chinese Medicine into the 11th edition of the International Classification of Diseases (ICD-11), a decision that remains controversial. While WHO officials clarified that the inclusion did not endorse the efficacy or safety of animal-based treatments, the symbolic legitimacy proved impossible to contain. Wildlife poachers, traffickers, and farming operations seized on the move as international validation.

Six years later, the consequences are measurable. Sales of wildlife-derived TCM products have grown, not shrunk. Regulatory agencies continue to issue quotas for pangolin scales, bear bile, and other endangered-species-derived medicines. The ICD-11 chapter—now in widespread use for insurance claims, diagnosis, and research—has become a backdoor through which illicit wildlife products gain the veneer of medical legitimacy.

The lesson, largely unlearned: international health bodies cannot separate the symbolic weight of their decisions from their practical consequences. Saying "we don't endorse it" is not the same as excluding it.

China's wildlife farming: Rural economy, pandemic risk

Since the 2003 SARS outbreak—which jumped from bats to civets to humans—the Chinese government has had clear evidence that wildlife farming amplifies zoonotic disease risk. Yet between 2003 and 2024, the opposite policy trajectory occurred. China's leadership, through the State Forestry and Grassland Administration, actively promoted "wildlife domestication" as a pillar of rural development and poverty alleviation.

By 2024, the Chinese wildlife farming industry was valued at over $100 billion. Civet cats, raccoon dogs, badgers, and other wild mammals were being raised in close proximity to humans and livestock—precisely the conditions epidemiologists warn create spillover risk. Government subsidies flowed to farmers who expanded operations. Trade quotas grew.

The 2020 temporary ban during COVID-19's height lasted only weeks. By 2021, farming operations resumed. No fundamental restructuring of the industry occurred. No systematic shift toward synthetic alternatives to animal products. Instead, the industry adapted: farms became slightly better regulated on paper, but the underlying demand and supply system persisted.

In 2023, a novel coronavirus emerged in a farming region of Guangxi Province. It did not spread globally, but it served as a warning that went largely unheeded. The machinery for another outbreak remained in place.

The dark web's evolution: Harder to monitor, not harder to access

In 2020, the dark web was still somewhat exotic to mainstream discourse. By 2026, it has become routine infrastructure for illicit trade—and far more sophisticated. Cryptocurrency mixing, decentralized marketplaces, and encrypted communications have made wildlife trafficking tracking exponentially harder for law enforcement.

More significantly, a second trend has emerged: the legitimization of wildlife trade on the regular internet. What once required anonymity now operates openly on regulated platforms. Licensed exporters in China advertise pangolin scales, rhinoceros horn remedies, and tiger bone wine on legitimate e-commerce sites, classified as "traditional medicine" rather than "endangered species products." International customs and wildlife enforcement agencies struggle to distinguish between legally sanctioned domestic trade and smuggling.

The irony is sharp: law enforcement spent years learning to monitor the dark web, only to discover that the real volume of trade had migrated to the light web, where it hides behind regulatory gray zones and international classification ambiguities.

Cyber sovereignty as pandemic enabler

The concept of "cyber sovereignty"—a government's assertion of control over internet activity within its borders—has only hardened since 2020. China's Cybersecurity Law, built on this principle, allows the government to regulate, censor, and even promote specific online commerce depending on political and cultural priorities.

This creates a curious inversion: while the dark web is suppressed and monitored, the regulated Chinese internet has become a more efficient marketplace for illicit wildlife products. A seller can operate with government tacit approval by classifying goods as Traditional Chinese Medicine. International buyers can access Chinese e-commerce platforms openly. Payment processors, shipping companies, and regulatory bodies all participate in a system that appears legal because it operates within the bounds of cyber-sovereign Chinese governance.

Meanwhile, cybercriminals globally benefit from access to a massive customer base through these legitimized channels. The risk is diffused—not concentrated on a few dark web markets, but distributed across thousands of vendors operating in plain sight.

What changed. What didn't.

Since 2020, some progress has occurred:

  • International wildlife trade regulations have tightened on paper. CITES (the Convention on International Trade in Endangered Species) now explicitly monitors online sales. Some platforms have banned wildlife trafficking.
  • Scientific consensus on zoonotic disease risk has hardened. Major institutions now publish research on spillover probability from wildlife trade.
  • Some nations have banned or severely restricted wildlife farming. India, Vietnam, and parts of Southeast Asia have made measurable progress.

But structural change has been limited:

  • China has not fundamentally restructured its wildlife farming industry or animal-based medicine supply chain.
  • International pressure on China has proven ineffective; if anything, "cyber sovereignty" rhetoric has made Beijing more resistant to external criticism of domestic regulatory choices.
  • No major alternatives to animal-derived traditional medicine have been scaled up. The industry continues to treat demand as fixed rather than addressable through innovation.
  • Internet governance continues to create asymmetries: high surveillance of truly illicit activity paired with low enforcement of activities that hide behind regulatory classification.

The geopolitical complication

By 2026, the question of wildlife farming has become entangled with broader US-China tensions. Any call for restrictions on Chinese wildlife trade is easily reframed as "Western interference in Chinese sovereignty." This has the perverse effect of making pandemic prevention a geopolitical football.

Meanwhile, new diseases continue to emerge. Monkeypox mutations, avian influenza variants, and novel coronaviruses have all jumped from animals to humans in the past six years. Each time, health authorities trace the spillover to wildlife contact—whether in wet markets, farming operations, or unregulated trade. Each time, the response focuses on vaccination and treatment rather than prevention at source.

What needs to change

The problem is not technology. It is not even cybersecurity in the narrow sense. The problem is that three regulatory regimes—health (WHO), environment (CITES), and internet governance (national cyber sovereignty laws)—are operating independently and often at cross-purposes.

Fixing this requires:

Honest accounting of TCM costs. The WHO should commission an independent assessment of whether animal-derived traditional medicine produces health benefits that justify pandemic risk. If the answer is yes, it needs to say so clearly and fund research into safer production. If no, the ICD-11 chapter should be reconsidered.

Structural change in China's rural economy. Poverty alleviation programs should shift investment from wildlife farming to alternative livelihoods. This is not punishment; it is enlightened self-interest. Another pandemic origin in Chinese territory will exact a far higher economic cost than retraining farmers.

Internet governance coordination. Cyber sovereignty is a real concept, but it cannot mean the right to operate high-risk industries on the grounds of cultural preference. International agreements on dangerous commodities (weapons, certain chemicals) already limit sovereign freedom. Wildlife products should be treated similarly.

Shifted burden of proof. Rather than requiring proof that a product is dangerous before restricting it, the burden should be reversed: proof that an animal-derived product is necessary and safe before it enters commerce at scale.

Conclusion

Six years after COVID-19, the world has largely moved on. Masks are gone. Borders reopened. Economic growth resumed. But the structural conditions that enabled a bat virus to become a global pandemic remain in place, waiting.

The difference between 2020 and 2026 is that we cannot claim ignorance. We know where spillover happens. We know which industries amplify risk. We know which internet governance structures enable trade in dangerous commodities. The question now is whether governments will treat pandemic prevention as a genuine priority or continue treating it as something to respond to after catastrophe strikes.

Based on current trajectories, the answer appears clear. The machinery for the next outbreak is not only intact—it is growing.